TriSalus Life Sciences to Host Virtual KOL Event on December 15, 2025 to Discuss TriNav Infusion System for Thyroid Disease Treatment.

jueves, 4 de diciembre de 2025, 4:03 pm ET1 min de lectura
TLSI--

TriSalus Life Sciences will host a virtual KOL event on December 15, 2025, to discuss the TriNav Infusion System for symptomatic thyroid disease. The event will feature Juan C. Camacho, MD, and will cover the unmet need, current treatment landscape, and the TriNav Infusion System's Pressure-Enabled Delivery for Thyroid Artery Embolization (PED-TAE) approach. A question and answer session will follow the presentations. The event aims to provide an overview of the TriNav Infusion System and its potential benefits for patients with symptomatic thyroid disease.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios